The NIH plans an extra layer of review for scientists with at least $1.5 million in existing grants.
Daily News Roundup
The NIH plans an extra layer of review for scientists with at least $1.5 million in existing grants.
A new report outlines ways in which omics-based technologies can be shuttled more safely and effectively from the bench to the clinic.
Mice “avatars” grafted with patient tumor tissue help identify effective drug regimens.
A second advisor for the National Children’s Study resigns in response to changes in study design.
One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.
The Federal Research Public Access Act faces stiff opposition from the Association American of Publishers.
NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.
Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.
The federal agency unveils a collection of thousands of genetic tests for some 2,500 diseases.
Legislators have dropped the Research Works Act, which would have nixed policies that require federally funded research findings to be deposited in public databases.